Integral Health Asset Management, LLC Celldex Therapeutics, Inc. Transaction History
Integral Health Asset Management, LLC
- $1.12 Billion
- Q4 2024
A detailed history of Integral Health Asset Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 300,000 shares of CLDX stock, worth $5.98 Million. This represents 1.2% of its overall portfolio holdings.
Number of Shares
300,000Holding current value
$5.98 Million% of portfolio
1.2%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$101 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$93.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$77.4 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$74.8 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$70.9 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $932M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...